Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 10 records per page: next > | last >>
pages: 1 2 3 4 5 ... 7 8 9 10 presentations: 1 to 50 of 463
Discussion with Audience Questions and Answers
Allison L. Agwu
Johns Hopkins University
Victor Reyes
Howard University, Washington, DC, USA
from CROI 2024 on March 4, 2024 4:00 PM-5:30 PM
Epidemiology of Perinatally Acquired HIV Among Adolescents and Young Adults   (ABSTRACT 21)
Mutsawashe F. Bwakura-Dangarembizi
University of Zimbabwe, Harare, Zimbabwe
from CROI 2024 on March 4, 2024 4:00 PM-5:30 PM
Historic Evolution of HIV and Mental Well-Being Among Adults Living With Perinatally Acquired HIV   (ABSTRACT 22)
Ezer Kang
Howard University, Washington, DC, USA
from CROI 2024 on March 4, 2024 4:00 PM-5:30 PM
Cardiometabolic Risks and Complications: Adolescents and Young Adults With Perinatally Acquired HIV   (ABSTRACT 23)
Sahera Dirajlal-Fargo
Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA
from CROI 2024 on March 4, 2024 4:00 PM-5:30 PM
Discussion with Audience Questions and Answers
Georgia D. Tomaras
Duke University, Durham, NC, USA
Leonidas Stamatatos
Fred Hutchison Cancer Center, Seattle, WA, USA
from CROI 2024 on March 4, 2024 4:00 PM-5:30 PM
Neutralizing Antibody Protection: Where Do We Go From Here?   (ABSTRACT 18)
Yunda Huang
Fred Hutchison Cancer Center, Seattle, WA, USA
from CROI 2024 on March 4, 2024 4:00 PM-5:30 PM
Germline Targeting Strategies to Get On the Road Again   (ABSTRACT 19)
Rogier W. Sanders
Academic Medical Center, Amsterdam, Netherlands
from CROI 2024 on March 4, 2024 4:00 PM-5:30 PM
Novel Immunization Strategies to Move on Down the Road   (ABSTRACT 20)
Darrell Irvine
Massachusetts Institute of Technology, Cambridge, MA, USA
from CROI 2024 on March 4, 2024 4:00 PM-5:30 PM
Discussion with Audience Questions and Answers
Jodie A. Dionne
University of Alabama at Birmingham, Birmingham, AL, USA
Alex de Voux
University of Cape Town, Cape Town, South Africa
from CROI 2024 on March 4, 2024 4:00 PM-5:30 PM
Why Can't We Do Better at Diagnosing Syphilis?   (ABSTRACT 24)
Ina Park
University of California San Francisco, San Francisco, CA, USA
from CROI 2024 on March 4, 2024 4:00 PM-5:30 PM
The Burgeoning Epidemic of Congenital Syphilis   (ABSTRACT 25)
Angelica Espinosa Miranda
Ministry of Health, Brasilia, Brazil
from CROI 2024 on March 4, 2024 4:00 PM-5:30 PM
Syphilis Management Conundrums   (ABSTRACT 26)
Khalil G. Ghanem
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2024 on March 4, 2024 4:00 PM-5:30 PM
Overview of the Global Displacement Crisis
Mesfin Teklu Tessema
International Rescue Committee
Panelist Reflections on the Global Displacement Crisis
Meeting the Needs of People Affected by HIV From Ukraine
Milosz Parczewski
Pomeranian Medical University, Szczecin, Poland
Protracted Consequences of Displacement: A Perspective From Latin America
Omar M. Sued
Pan American Health Organization, Washington, DC, USA
Lived Experience From Ukraine
Yana Panfilova
Teenergizer, Kyiv, Ukraine
Roundtable Discussion
Wafaa El-Sadr
Columbia University, New York, NY, USA
Roundtable Discussion
Mesfin Teklu Tessema
International Rescue Committee
Roundtable Discussion
Carlos del Rio
Emory University, Atlanta, GA, USA
Roundtable Discussion
Milosz Parczewski
Pomeranian Medical University, Szczecin, Poland
Roundtable Discussion
Yana Panfilova
Teenergizer, Kyiv, Ukraine
Roundtable Discussion
Omar M. Sued
Pan American Health Organization, Washington, DC, USA
from CROI 2024 on March 5, 2024 4:00 PM-5:30 PM
Novel Markers of Hepatitis B: Clinical Utility for New Treatment Strategies   (ABSTRACT 32)
Fabien Zoulim
L’Université Claude Bernard Lyon 1, Lyon, France
from CROI 2024 on March 5, 2024 4:00 PM-6:00 PM
Advances in HBV Immunotherapy: The Beginning of the End?   (ABSTRACT 33)
Adam Gehring
University of Toronto, Toronto, Canada
from CROI 2024 on March 5, 2024 4:00 PM-6:00 PM
How New WHO Guidance Can Transform Hepatitis B in Sub-Saharan Africa   (ABSTRACT 34)
Olufunmilayo Lesi
World Health Organization, Geneva, Switzerland
from CROI 2024 on March 5, 2024 4:00 PM-6:00 PM
International Perspectives on Hepatitis B: Panel Discussion
David L. Thomas
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Weston Spurr
Person with Lived Experience, Denver, Colorado
Anna S. Lok
University of Michigan, Ann Arbor, MI, USA
Fabien Zoulim
L’Université Claude Bernard Lyon 1, Lyon, France
Chien-Ching Hung
National Taiwan University Hospital, Taipei City, Taiwan
Hugo Perazzo
Oswaldo Cruz Foundation - Fiocruz, Rio de Janeiro, Brazil
Olufunmilayo Lesi
World Health Organization, Geneva, Switzerland
from CROI 2024 on March 5, 2024 4:00 PM-6:00 PM
Discussion with Audience Questions and Answers
Owen Pornillos
University of Utah, Salt Lake City, UT, USA
Melissa Kane
University of Pittsburgh, Pittsburgh, PA, USA
from CROI 2024 on March 5, 2024 4:00 PM-5:30 PM
HIV-1 Genome Packaging During Virion Assembly: Selecting the Right RNA   (ABSTRACT 29)
Wei-Shau Hu
National Cancer Institute, Frederick, MD, USA
from CROI 2024 on March 5, 2024 4:00 PM-5:30 PM
Virion Maturation: Folding Into the Right Shape   (ABSTRACT 30)
Mamuka Kvaratskhelia
University of Colorado, Aurora, CO, USA
from CROI 2024 on March 5, 2024 4:00 PM-5:30 PM
Virion Disassembly: Keeping it Together Until the Right Moment   (ABSTRACT 31)
Gregory Towers
University College London, London, UK
from CROI 2024 on March 5, 2024 4:00 PM-5:30 PM
Discussion with Audience Questions and Answers
Kenneth Ngure
Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
Michael Traeger
Burnet Institute, Melbourne, VIC, Australia
from CROI 2024 on March 5, 2024 4:00 PM-5:30 PM
Introduction to DoxyPEP: Understanding the Issues   (ABSTRACT 35)
Chase A. Cannon
University of Washington, Seattle, WA, USA
from CROI 2024 on March 5, 2024 4:00 PM-5:30 PM
DoxyPEP: Should We Worry About Antimicrobial Resistance?   (ABSTRACT 36)
Beatrice B.S.L. Bercot
St Louis Hospital, Paris, France
from CROI 2024 on March 5, 2024 4:00 PM-5:30 PM
Implementation of DoxyPEP: Challenges and Opportunities   (ABSTRACT 37)
Stephanie E. Cohen
San Francisco Department of Public Health, San Francisco, CA, USA
from CROI 2024 on March 5, 2024 4:00 PM-5:30 PM
Overview of the REPRIEVE Trial
Steven K. Grinspoon
Massachusetts General Hospital, Boston, MA, USA
from CROI 2024 on March 6, 2024 4:00 PM-5:30 PM
Sex Differences in Atherosclerotic CVD Risks and Mechanisms: Insights From REPRIEVE   (ABSTRACT 45)
Markella V. Zanni
Massachusetts General Hospital, Boston, MA, USA
from CROI 2024 on March 6, 2024 4:00 PM-5:30 PM
Immunomodulation and Cardiovascular Disease: Lessons Learned From HIV   (ABSTRACT 46)
Priscilla Y. Hsue
University of California San Francisco, San Francisco, CA, USA
from CROI 2024 on March 6, 2024 4:00 PM-5:30 PM
Implications for Implementing CVD Risk Prevention Strategies for Low- and Middle-Income Countries   (ABSTRACT 47)
Mpiko Ntsekhe
University of Cape Town, Cape Town, South Africa
from CROI 2024 on March 6, 2024 4:00 PM-5:30 PM
Panel Discussion
from CROI 2024 on March 6, 2024 4:00 PM-5:30 PM
Discussion with Audience Questions and Answers
María Buzón
Vall d'Hebron Research Institute, Barcelona, Spain
Alberto Bosque
George Washington University
from CROI 2024 on March 6, 2024 4:00 PM-5:30 PM
From Mechanisms to Therapeutics: Eliminating HIV-Infected Cells by the CARD8 Inflammasome   (ABSTRACT 41)
Liang Shan
Washington University in St Louis, St Louis, MO, USA
from CROI 2024 on March 6, 2024 4:00 PM-5:30 PM
From Mechanisms to Therapeutics: TACK Molecules Kill HIV-Infected Cells Through Inflammasome Activation   (ABSTRACT 42)
Tracy L. Diamond
Merck & Co., Inc., Rahway, NJ, USA
from CROI 2024 on March 6, 2024 4:00 PM-5:30 PM
From Transcriptomics to Therapeutics: A Host Restriction Factor That Targets HIV Expression   (ABSTRACT 43)
Rasmi Thomas
Walter Reed Army Institute of Research, Silver Spring, MD, USA
from CROI 2024 on March 6, 2024 4:00 PM-5:30 PM
From Structure to Therapeutics: CD4 Mimetics 'Open' Env and Sensitize HIV-1-Infected Cells to ADCC   (ABSTRACT 44)
Andrés Finzi
Université de Montréal, Montreal, Canada
from CROI 2024 on March 6, 2024 4:00 PM-5:30 PM
Introduction
Linda-Gail Bekker
Desmond Tutu HIV Foundation, Cape Town, South Africa
Bruno Spire
Institut National de la Santé et de la Recherche Médicale, Marseille, France
from CROI 2024 on March 6, 2024 4:00 PM-5:30 PM
Why Is Cabotegravir Rollout So Slow?   (ABSTRACT 48)
Rupa R. Patel
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2024 on March 6, 2024 4:00 PM-5:30 PM
The Ring Comes Full Circle: Navigating the Complex Landscape of Biomedical Prevention Post-Phase III   (ABSTRACT 49)
Leila E. Mansoor
Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
from CROI 2024 on March 6, 2024 4:00 PM-5:30 PM
Challenging the Dogma of Event-Driven PrEP   (ABSTRACT 50)
Jenell Stewart
Hennepin Healthcare Research Institute, Minneapolis, MN, USA
from CROI 2024 on March 6, 2024 4:00 PM-5:30 PM
Panel Discussion
Linda-Gail Bekker
Desmond Tutu HIV Foundation, Cape Town, South Africa
Bruno Spire
Institut National de la Santé et de la Recherche Médicale, Marseille, France
from CROI 2024 on March 6, 2024 4:00 PM-5:30 PM
SESSION OVERVIEW - DELIVERING ON THE SUCCESS OF INJECTABLE PrEP
Raphael J. Landovitz
University of California Los Angeles, Los Angeles, CA, United States
Christina Psaros
Massachusetts General Hospital, Boston, MA, United States
from CROI 2023 on February 20, 2023 4:00 PM-5:30 PM
FROM EFFICACY TO EFFECTIVENESS: CATALYZING ROLLOUT OF LONG ACTING PREP   (ABSTRACT 23)
Nyaradzo M. Mgodi
University of Zimbabwe, Harare, Zimbabwe
from CROI 2023 on February 20, 2023 4:00 PM-5:30 PM
INEVITABLE INEQUALITIES: WHY ME KEEP MAKING THE SAME MISTAKES AND HOW WE CAN STOP IT   (ABSTRACT 24)
Laron E. Nelson
Yale University, New Haven, CT, United States
from CROI 2023 on February 20, 2023 4:00 PM-5:30 PM
LA PrEP: WHAT WE KNOW AND WHAT WE STILL NEED TO KNOW   (ABSTRACT 25)
Sunil S. Solomon
The Johns Hopkins University School of Medicine, Baltimore, MD, United States
from CROI 2023 on February 20, 2023 4:00 PM-5:30 PM
DISCUSSION WITH ANSWERS TO AUDIENCE QUESTIONS
Raphael J. Landovitz
University of California Los Angeles, Los Angeles, CA, United States
Christina Psaros
Massachusetts General Hospital, Boston, MA, United States
from CROI 2023 on February 20, 2023 4:00 PM-5:30 PM
SESSION OVERVIEW - FROM ROCKET SCIENCE TO REALITY: MONITORING ANTIRETROVIRALS AND ADHERENCE
K. Rivet Amico
University of Michigan, Ann Arbor, MI, United States
Angela D.M. Kashuba
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
from CROI 2023 on February 20, 2023 4:00 PM-5:30 PM
THE LANDSCAPE OF ADHERENCE TESTING   (ABSTRACT 20)
Peter L. Anderson
University of Colorado Anschutz Medical Campus, Aurora, CO, United States
from CROI 2023 on February 20, 2023 4:00 PM-5:30 PM
DIGITAL TECHNOLOGIES FOR SUPPORTING ADHERENCE   (ABSTRACT 21)
Lisa Hightow-Weidman
Florida State University, Tallahassee, FL, United States
from CROI 2023 on February 20, 2023 4:00 PM-5:30 PM
CONSIDERATIONS FOR MEASURING ADHERENCE WITH LA/ED THERAPIES IN LOW- AND MIDDLE-INCOME   (ABSTRACT 22)
Catherine Orrell
Desmond Tutu Health Foundation, Cape Town, South Africa
from CROI 2023 on February 20, 2023 4:00 PM-5:30 PM
DISCUSSION WITH ANSWERS TO AUDIENCE QUESTIONS
K. Rivet Amico
University of Michigan, Ann Arbor, MI, United States
Angela D.M. Kashuba
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
from CROI 2023 on February 20, 2023 4:00 PM-5:30 PM
<< first | < prev page: of 10 records per page: next > | last >>
pages: 1 2 3 4 5 ... 7 8 9 10 presentations: 1 to 50 of 463